BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/10/2022 5:40:20 AM | Browse: 375 | Download: 805
 |
Received |
|
2021-12-22 15:50 |
|
Peer-Review Started |
|
2021-12-22 15:51 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-01-08 07:20 |
|
Revised |
|
2022-01-14 16:23 |
|
Second Decision |
|
2022-04-27 02:38 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-04-28 02:02 |
|
Articles in Press |
|
2022-04-28 02:02 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-05-26 08:32 |
|
Publish the Manuscript Online |
|
2022-06-10 05:40 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Florian Mourey, Amélie Decherf, Jean-François Jeanne, Mathieu Clément-Ziza, Marie-Lise Grisoni, François Machuron, Sophie Legrain-Raspaud, Arnaud Bourreille and Pierre Desreumaux |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Florian Mourey, MSc, Research Scientist, Research and Applications Department, Gnosis by Lesaffre, Lesaffre Group, 137 rue Gabriel Péri, Marcq-en-Baroeul 59700, France. f.mourey@gnosis.lesaffre.com |
| Key Words |
Probiotic; Yeast; Saccharomyces cerevisiae; Irritable bowel syndrome; Abdominal pain; Quality of life |
| Core Tip |
The gut microbiota has been proposed as central in irritable bowel syndrome (IBS) pathophysiology, and microbiota-directed intervention has therefore drawn considerable interest. Probiotics have been recognized as a potential solution for acting on the multifactorial causes and clinical symptoms of IBS. Among them, Saccharomyces cerevisiae (S. cerevisiae) CNCM I-3856 is a probiotic yeast that has shown beneficial effects on gastrointestinal symptoms of individuals with IBS, especially in IBS subjects with predominant constipation. This clinical study confirmed the abdominal pain alleviation properties of S. cerevisiae I-3856 in IBS with predominant constipation and showed improvements in quality of life in the group receiving the probiotic. |
| Publish Date |
2022-06-10 05:40 |
| Citation |
Mourey F, Decherf A, Jeanne JF, Clément-Ziza M, Grisoni ML, Machuron F, Legrain-Raspaud S, Bourreille A, Desreumaux P. Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation. World J Gastroenterol 2022; 28(22): 2509-2522 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i22/2509.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i22.2509 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
